Treatment of Acute Pharyngo-Tonsillitis With Essential Oils of Aromatic Plants

HaEmek Medical Center, Israel33 enrolled

Overview

This randomized, double blind, parallel group study, compared the efficacy of spray containing aromatic essential oils of some herbal plants, against placebo in the treatment of patients with acute viral Pharyngo-tonsillitis. Study objectives: Primary to demonstrate a throat pain relief within 20 minutes after first administration of treatment with the spray. Secondary to demonstrate a reduction of a defined symptoms sum score based on symptoms and signs comparing baseline therapy from the beginning to the end of 3 days treatment

This study compared the efficacy of spray containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, against placebo in the treatment of patients with acute viral Pharyngo-tonsillitis. In- vitro and clinical studies suggest therapeutic potential of aromatic herbs and trees oils in the treatment of Pharyngo-Tonsillitis. The pharmacological and clinical activity of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, include anti-inflammatory, anti-bacterial and anti-viral activities. Some of these herbs and trees oils have direct activity on the respiratory tract, the coughing reflex and the airflow in the nasal tract.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Viral Pharyngitis

Interventions

mixture of aromatic essential oils.DIETARY_SUPPLEMENT

3% of mixture containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, spraying to the throat.

placeboDIETARY_SUPPLEMENT

0:1% of Lemon VIP (Florasynth,Israel), spraying to the throat.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of acute viral pharyngo-tonsillitis. * Active disease less than 48 hours * Patients agree to sign informed consent according to GCP and Israel national regulations. Exclusion Criteria: * Acute follicular tonsillitis. * Peritonsillar abscess. * Under any antibiotically treatment. * Asthma disease. * Under coumadine therapy. * Hyper sensitivity to Aromatic essential oils. * Any immuno-suppressive disease

Outcomes

Primary Outcomes

To demonstrate a throat pain relief within the first 20 minutes after first administration of treatment with the spray.

Time frame: 20 minutes

Secondary Outcomes

To demonstrate a reduction of a defined symptoms sum score based on symptoms and signs comparing baseline therapy from the beginning to the end of 3 days treatment.

Time frame: 3 days